Multiple-drug therapy in Hodgkin's disease.
D000932:Antiemetics / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000009:adverse effects / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011344:Procarbazine / Q000009:adverse effects / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D000932:Antiemetics; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone